DXCM NASDAQ
DexCom, Inc.
1W: -8.6%
1M: -9.3%
3M: +5.0%
YTD: +18.1%
1Y: +10.6%
3Y: -8.7%
5Y: -41.9%
$78.56
-0.01 (-0.01%)
After Hours: $79.38 (+0.82, +1.04%)
Weekly Expected Move ±5.2%
$70
$74
$78
$82
$86
Credit Risk of going bust: lower than 80% of companies Debt: 4.5% of company value Bonds: $105.4M held by 25 funds → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.29 (down 99.6%), DexCom, Inc. would be worth roughly what it owes.
Total debt $1.40B against a stock market value of $29.65B.
Distance to default 9.72 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $621.4M (short-term plus half of long-term), stock volatility 40.4%; Altman Z 7.02. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $0.29 (down 99.6%), DexCom, Inc. would be worth roughly what it owes.
Total debt $1.40B against a stock market value of $29.65B.
Distance to default 9.72 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $621.4M (short-term plus half of long-term), stock volatility 40.4%; Altman Z 7.02. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (24h)
1
Hourly Sentiment (24h)
0.00
Neutral
1 bullish
1 neutral
1 bearish
Articles (7d)
3
Daily Sentiment (7 Days)
Articles (100)
DexCom Gears Up to Report Q3 Results: How to Play the Stock?
Notable healthcare headlines for the week: Moderna, Roche, and Abbott Laboratories in focus
Midday Pulse: S&P 500 top intraday losers
DexCom's G7 Shows Strong Results in Type 2 Diabetes CONNECT Study
DexCom (NASDAQ:DXCM) EVP Michael Jon Brown Sells 1,700 Shares of Company Stock
Vaso Stock Surges 149% in a Year: What's Behind the Rally?
These S&P 500 stocks lead in capital efficiency - BofA
DexCom gains as NEJM publication boosts Medicare coverage hopes
Here's Why You Should Retain DexCom Stock in Your Portfolio for Now
Notable healthcare headlines for the week: Novavax, Moderna and Becton Dickinson in focus
DexCom, Inc. $DXCM Stake Decreased by Bell Asset Management Ltd
96,427 Shares of DexCom, Inc. $DXCM Bought by HWG Holdings LP
DexCom, Inc. $DXCM Shares Newly Acquired by Bright Rock Capital Management LLC
DXCM Report Highlights CGM Growth Opportunity in Type 2 Diabetes Care
Here's Why DexCom (DXCM) is a Strong Growth Stock
Find alpha in the revenue growth fog - Goldman
DexCom, Inc. (NASDAQ:DXCM) Stock Rated “Moderate Buy” by Wall Street Brokerages
Nykredit A S Invests $8.06 Million in DexCom, Inc. $DXCM
Notable healthcare headlines for the week: Novo Nordisk, GE HealthCare, and Eli Lilly in focus
Stock futures mixed as Fed rate decision takes center stage
DexCom expands CFO’s role to COO
Here's Why You Should Retain DexCom Stock in Your Portfolio for Now
Why DexCom (DXCM) is a Top Growth Stock for the Long-Term
Here's How Much a $1000 Investment in DexCom Made 10 Years Ago Would Be Worth Today
Algert Global LLC Grows Position in DexCom, Inc. $DXCM
Bamco Inc. NY Purchases Shares of 245,000 DexCom, Inc. $DXCM
American Capital Management Inc. Purchases Shares of 235,152 DexCom, Inc. $DXCM
Abbott vs. DexCom: Which CGM Stock Is the Better Buy Now?
Can PODD Sustain Growth After Its 2026 Guidance Reset and Q2 Beat?
Stock futures edge higher as Nvidia results, inflation data loom
Great Lakes Advisors LLC Invests $369,000 in DexCom, Inc. $DXCM
Here's Why DexCom (DXCM) is a Strong Momentum Stock
Aurora Investment Counsel Invests $2.34 Million in DexCom, Inc. $DXCM
Is IDXX Worth Buying as Growth Strength Meets a Premium Valuation?
Empowered Funds LLC Grows Stake in DexCom, Inc. $DXCM
Notable healthcare headlines for the week: Eli Lilly, Hims & Hers Health, and Merck in focus
Here's Why DexCom (DXCM) is a Strong Growth Stock
Here's How Much You'd Have If You Invested $1000 in DexCom a Decade Ago
Is DXCM Stock Worth Buying as Growth Improves but Valuation Stretches?
DXCM Stock Up Nearly 35% YTD: Will the Uptrend Continue in the Rest of 2026?
Can DexCom's Raised 2026 Outlook Sustain Stronger Margin Momentum?
DXCM Rallies 52.5% in 3 Months. Can the Stock Keep Climbing From Here?
$TTD will be $20+ within a year
Assenagon Asset Management S.A. Has $46.72 Million Holdings in DexCom, Inc. $DXCM
DexCom (DXCM) Q2 2026 Earnings Call Transcript
DexCom (DXCM) Recently Broke Out Above the 20-Day Moving Average
Best Health & Fitness Stocks for Investors Amid Wellness Boom
DexCom, Inc. (DXCM) Hit a 52 Week High, Can the Run Continue?
Notable healthcare headlines for the week: Curium, Bristol-Myers Squibb, and Johnson & Johnson in focus
Earnings scorecard: eight out of nine healthcare companies deliver EPS wins this week
July healthcare recap: Regeneron, DexCom shine as Moderna, managed-care stocks retreat
DexCom Stock Up on Q2 Earnings & Revenue Beat, Margins Rise
Dexcom lifts 2026 revenue outlook to $5.18B-$5.25B as it targets nearly 50% U.S. G7 15 Day conversion by year-end
DexCom, Inc. Q2 2026 Earnings Call Summary
DexCom (DXCM) Q2 2026 Earnings Call Transcript
DexCom (DXCM) Q2 Earnings and Revenues Top Estimates
3 Beaten-Down Stocks With GLP-1 Exposure to Buy and Hold
Philips Q2 Earnings and Revenues Increase Year over Year, Shares Down
Watch These 4 Medical Product Stocks for Q2 Earnings: Beat or Miss?
Dimensional Fund Advisors LP Buys 23,844 Shares of DexCom, Inc. $DXCM
Why DexCom (DXCM) is a Top Growth Stock for the Long-Term
Abbott Rides Key Diabetes, Oncology and Heart Care Innovation Trends
DXCM Q2 Results Likely to Reflect Strong G7 & Reimbursement Expansion
Is Abbott Stock Attractive After Its Earnings and Guidance Update?
Notable healthcare headlines for the week: Eli Lilly, Molina Healthcare, and Roche in focus
DexCom (DXCM) Earnings Expected to Grow: Should You Buy?
Alamar Capital Management LLC Acquires Shares of 13,605 DexCom, Inc. $DXCM
Arvest Bank Trust Division Makes New $3.71 Million Investment in DexCom, Inc. $DXCM
Are Medical Stocks Lagging DexCom (DXCM) This Year?
Three themes emerge as AI momentum trade turns volatile: Goldman Sachs
Ithaka Group adds TSM, LRCX; exits NFLX, INTU among Q2 moves
DXCM Secures Health Canada Authorization for Dexcom G7 15 Day CGM
Notable healthcare headlines for the week: UnitedHealth, Vertex, and CVS Health in focus
Here's Why DexCom (DXCM) is a Strong Growth Stock
Here's Why You Should Retain DexCom Stock in Your Portfolio for Now
DexCom, Inc. (DXCM) Further Advances Vision of Glucose Biosensing for All
Notable healthcare headlines for the week: Merck, AbbVie, and Bayer in focus
Abbott vs. DexCom: Which CGM Stock Is the Better Option Right Now?
DexCom to Roll Out Reimagined Stelo App With Global Expansion Plans
Should You Buy Abbott Labs Stock Hand Over Fist Before July 16?
Here's How Much You Would Have Made Owning DexCom Stock In The Last 20 Years
DXCM Receives FDA Clearance for Stelo OTC CGM System for Children
Abbott's CGM Growth Story Stays Intact Despite Q1 Moderation
Here's Why DexCom (DXCM) is a Strong Growth Stock
Dexcom Scores Pediatric Expansion For OTC Stelo Glucose Monitor
Stock index futures mixed as traders gear up for SpaceX IPO
Why DexCom (DXCM) is a Top Momentum Stock for the Long-Term
Clinical Wins Boost Dexcom Growth Story In Type 2 Diabetes
DexCom Reports Positive CONNECT Data for Non-Insulin Diabetes
Here's Why You Should Retain DexCom Stock in Your Portfolio
DexCom vs. Insulet: Which Diabetes Stock Is a Better Buy in 2026?
Avanos Medical (AVNS) Up 1.1% Since Last Earnings Report: Can It Continue?
Abbott Addresses a Major Diabetes Care Gap With Tech Innovation
The Cooper Companies Gears Up to Post Q2 Earnings: What's in Store?
Tandem Diabetes Valuation: Is 1.1x Sales a Buy?
2 Growth Stocks to Buy and Hold for a Decade
TNDM Stock: What to Know About Tandem's 2026 Reset
PODD Stock: What a Hold Rating Says at a $163 Target
PODD and Omnipod 5: What's Driving Insulet's 2026 Growth
Why DexCom (DXCM) is a Top Growth Stock for the Long-Term